Search
for
Sort by
Research 61–90 of 1000+
- Validation of alopecia coding in US claims data among women of childbearing age
- Extraordinary claims without extraordinary evidence: controversy on anti‐androgen therapy for COVID‐19
- Wellness claims and men’s health: Bridging the counseling gap in urology
- Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis
- Ethno-medico-botanical claims of Bondla wildlife sanctuary vicinity of Goa
- UK High Court Revokes Escitalopram UK Patent; Validity of Second Medical use Claims Based on Dosage Regimes in the UK; Stay of Proceedings in the UK Courts Pending EPO Opposition Proceedings
- Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study
- Purpose-limited pharmaceutical product claims under the revised European Patent Convention: A camouflaged attack on generic substitution?
- Limiting Initial Interest Confusion Claims in Keyword Advertising
- Epidemiology of alopecia areata and population-wide comorbidities in Germany: analysis of longitudinal claims data
- 0519 Social media claims and tolerability of topical tretinoin plus topical minoxidil for androgenetic alopecia
- LibGuides: L3Y2 Tutorial 2022 - critical thinking: Claim 5: Caffeine reduces hair loss
- Red Light Therapy in Cosmetic Dermatology: Marketing Claims Backed by Evidence?
- Scientific Validation of "Clinically Proven" Claims: Compliance Focused and Global Regulatory Insights
- Patentability of dosage regime invention in the form of Swiss-type claim under Chinese patent law
- Cell-Based Model Systems for Validation of Various Efficacy-Based Claims for Cosmetic Ingredients
- Medical treatment methods, medical indication claims and patentability: A quest into the rationale of the exclusion and patentability in the context of the future of personalised medicine
- Can washing socks without flipping inside out cause hair tourniquet syndrome? A claim with two case reports
- Court of Appeal can overrule itself to follow the EPO: UK adopts EPO stance on second medical use claims
- Exosome Revolution or Marketing Mirage? AI-Based Multi-domain Evaluation of Claims, Scientific Evidence, Transparency, Public Sentiment, and Media Narratives
- Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case–control analysis using German claims data
- Identifying barriers and disparities in the healthcare of patients with alopecia areata: a mixed-methods analysis using claims data and qualitative interview data
- Prevalence of autoimmune and inflammatory diseases and mental health conditions among an alopecia areata cohort from a US administrative claims database
- Prevalence, comorbidities, and treatment patterns of Japanese patients with alopecia areata: A descriptive study using Japan medical data center claims database
- Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims
- A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database
- Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database
- Generic competition and pharma patent strategies - a sequel
- Book Reviews
- Recent European legal developments on second medical uses and dosage regimes